AwardedSpainGoodsFramework agreement€4,248,673
CONTR 2026 180732 CBAM-4 EXP 296/2024
- Published
- Published 25 June 2026
Overview
The Andalusian Health Service has awarded a framework agreement to GlaxoSmithKline, S.A. for the supply of herpes zoster vaccines for the Andalusia vaccination program. The agreement, valued at €4,418,619.92 and awarded on 21 May 2026, establishes unit prices and successive supply conditions for the vaccines.
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Estimated value
- €4,248,673
- Procedure
- Direct
- Contract type
- Framework agreement
- Published
- 25 June 2026
Vaccines
Award outcome
- Awarded value
- €4,418,620
- Award date
- 21 May 2026
- GLAXOSMITHKLINE, S.A.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
25 June 2026
Contracting authority
Servicio Andaluz de Salud. Hospital Universitario Virgen de las Nieves
Procuring entityGranada, Spain
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.